BIOCRYST PHARMACEUTICALS, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2020-06-30 was 22.04M shares.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2013-12-31 was -1.72M shares.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2021 was 3.85M shares, a 82.55% decline from fiscal 2020.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2020 was 22.04M shares, a 49.46% decline from fiscal 2019.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2019 was 43.62M shares.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2013 was 2.88M shares, a 36.16% decline from fiscal 2012.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2021-12-31 | 3.85M shares 10-K · filed 2024-02-27 | |
| 2020-12-31 | 22.04M shares 10-K · filed 2023-02-27 | |
| 2020-06-30 | 22.04M shares 10-Q · filed 2020-08-07 | |
| 2019-12-31 | 43.62M shares 10-K · filed 2022-02-28 | |
| 2013-12-31 | -1.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | 2.88M shares 10-K · filed 2016-02-26 |
| 2012-12-31 | 4.52M shares 10-K · filed 2016-02-26 | |
| 2011-12-31 | 437.00K shares 10-K · filed 2014-03-10 | |
| 2010-12-31 | 761.00K shares 10-K · filed 2013-03-11 | |
| 2009-12-31 | 5.00M shares 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |